Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    P05 - Early Stage/Localized Disease - Radiotherapy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P05.03 - Circulating Lymphocyte Counts after Lung Stereotactic Body Radiation Therapy May Predict after Optimal Short-term Efficacy

      00:00 - 00:00  |  Presenter: Meng Chen

      • Abstract

      Loading...

  • +

    P14 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Immuno-Biology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      P14.02 - Expression and Significance of Indoleamine 2,3 Dioxygenase on Tumor Cell and Tumor Stroma Compartments of Lung Squamous Cell Carcinoma

      00:00 - 00:00  |  Presenter: Wei Wang

      • Abstract

      Loading...

    • +

      P14.06 - Dysregulation of m6a Reader IGF2BP1 in Lung Adenocarcinoma Affects the Immune Microenvironment and Indicates a Poor Recovery

      00:00 - 00:00  |  Presenter: Xuequan Wang

      • Abstract

      Loading...

  • +

    P48 - Small Cell Lung Cancer/NET - Chemo - IO

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Small Cell Lung Cancer/NET
    • +

      P48.07 - Synergistic Antitumor Effects of Anlotinib Combination With Oral 5-Fluorouracil S-1 in Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Haihua Yang

      • Abstract

      Loading...

  • +

    P62 - Tumor Biology and Systems Biology - Basic and Translational Science - Metabolomics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P62.03 - Increased GPX4 Drives Ferroptosis Resistance by Suppressing Radiation-Induced Lipid Peroxidation Confers Acquired Radioresistance in NSCLC

      00:00 - 00:00  |  Presenter: Wei Wang

      • Abstract

      Loading...

  • +

    P65 - Tumor Biology and Systems Biology - Basic and Translational Science - NC RNA

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P65.01 - LncRNA UCA1 Induces Acquired Resistance to Gefitinib by Epigenetically Silencing CDKN1A Expression in non-small-cell lung cancer

      00:00 - 00:00  |  Presenter: Zhaoxia Wang

      • Abstract

      Loading...

  • +

    P69 - Tumor Biology and Systems Biology - Basic and Translational Science - RTK/EGFR

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P69.02 - Identification of Potential Core Gene in Immune Infiltrates of EGFR Mutant Lung Adenocarcinoma using Bioinformatics Analysis

      00:00 - 00:00  |  Presenter: Zhaoxia Wang

      • Abstract

      Loading...

  • +

    P82 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Radiotherapy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      P82.04 - Adaptive Radiation Therapy with Consolidation Sintilimab in Stage III NSCLC: Challenges in Recruiting Patients for Adjuvant Immunotherapy

      00:00 - 00:00  |  Presenter: Yinnan Meng

      • Abstract

      Loading...

  • +

    P86 - Targeted Therapy - Clinically Focused - New Target

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P86.20 - The Prevalence of NTRK1 Fusion in a Chinese Lung Cancer Cohort

      00:00 - 00:00  |  Presenter: Zhifang Liu

      • Abstract

      Loading...

  • +

    MA08 - Advances in Biomarkers for Immune Checkpoint Blockade and Targeted Therapy in Non Small Cell Lung Carcinoma

    • 16:45 - 17:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      MA08.09 - Clinical Management of Lung Adenocarcinoma Patients With HER2 V659E Mutation

      17:15 - 17:20  |  Presenter: Ziqi Jia

      • Abstract

      Loading...